Literature DB >> 20419592

Intermittent hypoxia does not affect endurance performance at moderate altitude in well-trained athletes.

Martin Faulhaber1, Hannes Gatterer, Thomas Haider, Carson Patterson, Martin Burtscher.   

Abstract

In this study, we examined the effects of a pre-acclimatization programme on endurance performance at moderate altitude using a resting intermittent hypoxia protocol. The time-trial performance of 11 cyclists was determined at low altitude (600 m). Athletes were randomly assigned in a double-blind fashion to the hypoxia or the control group. The pre-acclimatization programme consisted of seven sessions each lasting 1 h in normobaric hypoxia (inspired fraction of oxygen of 12.5%, equivalent to approximately 4500 m) for the hypoxia group (n = 6) and in normoxia (inspired fraction of oxygen of 20.9%) for the control group (n = 5). The time-trials were repeated at moderate altitude (1970 m). Mean power output during the time-trial at moderate altitude was decreased in the hypoxia group (-0.26 +/- 0.11 W x kg(-1)) and in the control group (-0.13 +/- 0.04 W x kg(-1)) compared with at low altitude but did not differ between groups (P = 0.13). Our results suggest that the applied protocol of intermittent hypoxia had no positive effect on endurance performance at moderate altitude. Whether different intermittent hypoxia protocols are advantageous remains to be determined.

Entities:  

Mesh:

Year:  2010        PMID: 20419592     DOI: 10.1080/02640410903581588

Source DB:  PubMed          Journal:  J Sports Sci        ISSN: 0264-0414            Impact factor:   3.337


  8 in total

Review 1.  Cardioprotection by intermittent hypoxia conditioning: evidence, mechanisms, and therapeutic potential.

Authors:  Robert T Mallet; Eugenia B Manukhina; Steven Shea Ruelas; James L Caffrey; H Fred Downey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-13       Impact factor: 4.733

2.  Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson's disease: study rationale and protocol.

Authors:  Jules M Janssen Daalen; Marjan J Meinders; Federica Giardina; Kit C B Roes; Bas C Stunnenberg; Soania Mathur; Philip N Ainslie; Dick H J Thijssen; Bastiaan R Bloem
Journal:  BMC Neurol       Date:  2022-07-14       Impact factor: 2.903

3.  Resting arterial oxygen saturation and breathing frequency as predictors for acute mountain sickness development: a prospective cohort study.

Authors:  Martin Faulhaber; Maria Wille; Hannes Gatterer; Dieter Heinrich; Martin Burtscher
Journal:  Sleep Breath       Date:  2014-01-17       Impact factor: 2.816

4.  Metabolic adaptations may counteract ventilatory adaptations of intermittent hypoxic exposure during submaximal exercise at altitudes up to 4000 m.

Authors:  Martin Faulhaber; Tobias Dünnwald; Hannes Gatterer; Luciano Bernardi; Martin Burtscher
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

5.  Heart rate and blood pressure responses during hypoxic cycles of a 3-week intermittent hypoxia breathing program in patients at risk for or with mild COPD.

Authors:  Martin Faulhaber; Hannes Gatterer; Thomas Haider; Tobias Linser; Nikolaus Netzer; Martin Burtscher
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-11

6.  Exercise-Induced Hypoxaemia Developed at Sea-Level Influences Responses to Exercise at Moderate Altitude.

Authors:  Anne-Fleur Gaston; Fabienne Durand; Emma Roca; Grégory Doucende; Ilona Hapkova; Enric Subirats
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

7.  Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Authors:  Barbara Strasser; Daniela Geiger; Markus Schauer; Johanna M Gostner; Hannes Gatterer; Martin Burtscher; Dietmar Fuchs
Journal:  Nutrients       Date:  2016-11-23       Impact factor: 5.717

8.  Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained Athletes.

Authors:  Barbara Strasser; Daniela Geiger; Markus Schauer; Hannes Gatterer; Martin Burtscher; Dietmar Fuchs
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.